|
1
|
Nickel JC: Management of urinary tract
infections: historical perspective and current strategies: Part 1 -
Before antibiotics. J Urol. 173:21–26. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Medina M and Castillo-Pino E: An
introduction to the epidemiology and burden of urinary tract
infections. Ther Adv Urol. 11(1756287219832172)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Flores-Mireles AL, Walker JN, Caparon M
and Hultgren SJ: Urinary tract infections: Epidemiology, mechanisms
of infection and treatment options. Nat Rev Microbiol. 13:269–284.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kranz J, Schmidt S, Lebert C, Schneidewind
L, Mandraka F, Kunze M, Helbig S, Vahlensieck W, Naber K,
Schmiemann G, et al: The 2017 update of the German clinical
guideline on epidemiology, diagnostics, therapy, prevention, and
management of uncomplicated urinary tract infections in adult
patients: Part 1. Urol Int. 100:263–270. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tandogdu Z and Wagenlehner FM: Global
epidemiology of urinary tract infections. Curr Opin Infect Dis.
29:73–79. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rădulescu A, Mădan V, Aungurenci A, Bratu
O, Farcaş C, Dinu M and Mischianu D: Antibiotic resistant urinary
tract infections in an urology ward. Rom J Mil Med. 118:20–22.
2015.
|
|
7
|
Zaha DC, Bungau S, Aleya S, Tit DM, Vesa
CM, Popa AR, Pantis C, Maghiar OA, Bratu OG, Furau C, et al: What
antibiotics for what pathogens? The sensitivity spectrum of
isolated strains in an intensive care unit. Sci Total Environ.
687:118–127. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vata A, Hunea IM, Dorneanu O, Harja-Alexa
IA, Plesca C, Leonte-Enache G, Ciocan A, Ghiciuc C, Esanu I,
Manolache M, et al: Biochemical changes and risk factors in the
prognosis of antibiotics susceptibility in urinary tract
infections. Rev Chim Buchar. 70:1822–1825. 2019.
|
|
9
|
Mihai IF, Lacatusu G, Filip-Ciubotaru F,
Dorobat C, Romanescu C and Manciuc C: Major trends in the microbial
etiology of urinary tract infection. GARJM. 8:35–37. 2019.
|
|
10
|
Miftode E, Dorneanu O, Leca D, Teodor A,
Mihalache D, Filip O and Luca V: Antimicrobial resistance profile
of E. coli and Klebsiella spp. from urine in the
Infectious Diseases Hospital Iaşi. Rev Med Chir Soc Med Nat Iasi.
112:478–482. 2008.PubMed/NCBI(In Romanian).
|
|
11
|
Anger J, Lee U, Ackerman AL, Chou R,
Chughtai B, Clemens JQ, Hickling D, Kapoor A, Kenton KS, Kaufman
MR, et al: Recurrent uncomplicated urinary tract infections in
women: AUA/CUA/SUFU Guideline. J Urol. 202:282–289. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Malik RD, Wu YR and Zimmern PE: Definition
of recurrent urinary tract infections in women: Which one to adopt?
Female Pelvic Med Reconstr Surg. 24:424–429. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Geerlings SE: Clinical presentations and
epidemiology of urinary tract infections. Microbiol Spectr: Oct 4,
2016 (Epub ahead of print). doi:
10.1128/microbiolspec.UTI-0002-2012.
|
|
14
|
Luc MC, Roșu F, Hurmuzache M, Luca AS,
Leca D, Iancu L and Ochiuz L: Updates in the assesment of risk
factors in Clostridium Difficile infection in patients with
infectious diseases. Farmacia. 64:112–115. 2016.
|
|
15
|
Paterson DL: ‘Collateral damage’ from
cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 38
(Suppl 4):S341–S345. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Schito GC, Naber KG, Botto H, Palou J,
Mazzei T, Gualco L and Marchese A: The ARESC study: An
international survey on the antimicrobial resistance of pathogens
involved in uncomplicated urinary tract infections. Int J
Antimicrob Agents. 34:407–413. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Scottish Intercollegiate Guidelines
Network (SIGN): Management of Suspected Bacterial Urinary Tract
Infection in Adults. Edinburgh: SIGN (SIGN publication no. 88),
pp1-46, 2012. Available from URL: http://www.sign.ac.uk.
Accessed November 10, 2019.
|
|
18
|
Glover M, Moreira CG, Sperandio V and
Zimmern P: Recurrent urinary tract infections in healthy and
nonpregnant women. Urol Sci. 25:1–8. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chwa A, Kavanagh K, Linnebur SA and Fixen
DR: Evaluation of methenamine for urinary tract infection
prevention in older adults: A review of the evidence. Ther Adv Drug
Saf. 10(2042098619876749)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Eells SJ, Bharadwa K, McKinnell JA and
Miller LG: Recurrent urinary tract infections among women:
Comparative effectiveness of 5 prevention and management strategies
using a Markov chain Monte Carlo model. Clin Infect Dis.
58:147–160. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ratiu MP, Purcarea I, Popa F, Purcarea VL,
Purcarea TV, Lupuleasa D and Boda D: Escaping the economic turn
down through performing employees, creative leaders and growth
driver capabilities in the Romanian Pharmaceutical Industry.
Farmacia. 59:119–129. 2011.
|
|
22
|
National Institute for Health and Care
Excellence NICE: NICE guideline NG15. Antimicrobial stewardship:
systems and processes for effective antimicrobial medicine use.
pp1-25, 2015. Available from URL: https://www.nice.org.uk/guidance/ng15.
Accessed November 10, 2019.
|
|
23
|
Grabe M, Baroletti R, Bjerklund Johansen
TE, Cai T, Çek M, Köves B, Naber KG, Pickard RS, Tenke P,
Wagenlehner F, et al: Guidelines on Urological Infections. European
Association of Urology. 2015. Available from URL: https://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf.
Accessed November 10, 2019.
|
|
24
|
Gopalakrishna P, Bonnie D, Richard Z and
Lacie D: Cranberry for the prevention and treatment of
non-nomplicated urinary tract infections. SOJ Pharm Sci. 6:1–9.
2018.
|
|
25
|
Vasileiou I, Katsargyris A, Theocharis S
and Giaginis C: Current clinical status on the preventive effects
of cranberry consumption against urinary tract infections. Nutr
Res. 33:595–607. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
MacMicking J, Xie QW and Nathan C: Nitric
oxide and macrophage function. Annu Rev Immunol. 15:323–350.
1997.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rhee KY and Charles M: Antimicrobial
mechanisms of cranberry juice. Clin Infect Dis.
39(877)2004.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Di Martino P, Agniel R, David K, Templer
C, Gaillard JL, Denys P and Botto H: Reduction of Escherichia
coli adherence to uroepithelial bladder cells after consumption
of cranberry juice: A double-blind randomized placebo-controlled
cross-over trial. World J Urol. 24:21–27. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lavigne JP, Bourg G, Combescure C, Botto H
and Sotto A: In-vitro and in-vivo evidence of dose-dependent
decrease of uropathogenic Escherichia coli virulence after
consumption of commercial Vaccinium macrocarpon (cranberry)
capsules. Clin Microbiol Infect. 14:350–355. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Guay DR: Cranberry and urinary tract
infections. Drugs. 69:775–807. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hung CS, Bouckaert J, Hung D, Pinkner J,
Widberg C, DeFusco A, Auguste CG, Strouse R, Langermann S, Waksman
G, et al: Structural basis of tropism of Escherichia coli to
the bladder during urinary tract infection. Mol Microbiol.
44:903–915. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hickling DR and Nitti VW: Management of
recurrent urinary tract infections in healthy adult women. Rev
Urol. 15:41–48. 2013.PubMed/NCBI
|
|
33
|
Vicariotto F: Effectiveness of an
association of a cranberry dry extract, D-mannose, and the two
microorganisms Lactobacillus plantarum LP01 and Lactobacillus
paracasei LPC09 in women affected by cystitis: A pilot study. J
Clin Gastroenterol. 48 (Suppl 1):S96–S101. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Panchev P, Slavov Ch, Mladenov D, Georgiev
M, Yanev K, Paskalev E, Simeonov P, Gerassi R, Bogov B and Saltirov
I: A multicenter comparative observation on the effectiveness and
the rapidness of the effect of Cystostop Rapid vs. antibiotic
therapy in patients with uncomplicated cystitis. Akush Ginekol
(Sofiia). 51:49–55. 2012.PubMed/NCBI(In Bulgarian).
|
|
35
|
Maisuria VB, Okshevsky M, Déziel E and
Tufenkji N: Proanthocyanidin interferes with intrinsic antibiotic
resistance mechanisms of gram-negative bacteria. Adv Sci (Weinh).
6(1802333)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jepson RG, Williams G and Craig JC:
Cranberries for preventing urinary tract infections. Cochrane
Database Syst Rev. 10(CD001321)2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Genovese C, Davinelli S, Mangano K,
Tempera G, Nicolosi D, Corsello S, Vergalito F, Tartaglia E,
Scapagnini G and Di Marco R: Effects of a new combination of plant
extracts plus d-mannose for the management of uncomplicated
recurrent urinary tract infections. J Chemother. 30:107–114.
2018.PubMed/NCBI View Article : Google Scholar
|
